Sb Pharma Solutions

Sb Pharma Solutions

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

SB Pharma Solutions, LLC, founded in 2015 and based in San Diego, is a privately held service provider specializing in medical affairs consulting for the pharmaceutical industry. The company leverages a team of experienced PharmDs and scientists to deliver strategic medical content, launch readiness support, and operational guidance across neurology, psychiatry, infectious disease, and rare disease therapeutic areas. With a core team of 7-8 professionals, the firm has demonstrated consistent year-over-year revenue growth by acting as an embedded partner for clients who lack extensive in-house medical affairs capabilities. Its business model is entirely service-based, catering to the outsourced needs of emerging and mid-size biopharma companies.

NeurologyPsychiatryInfectious DiseaseRare DiseasesMen's Health

Technology Platform

Service-based expertise in medical affairs strategy, medical writing, dossier preparation, and scientific communication design; no proprietary therapeutic technology.

Opportunities

The growing trend of outsourcing medical affairs functions by small and mid-sized biopharma companies, which often lack internal capacity, presents a significant and expanding market.
The increasing complexity of launch requirements and payer evidence needs further drives demand for specialized consulting services like those offered by SB Pharma Solutions.

Risk Factors

Revenue is project-based and reliant on a small client base, creating vulnerability to client loss and cash flow volatility.
The company operates in a competitive consulting landscape against both niche firms and large CROs, and its success is entirely dependent on attracting and retaining a limited pool of highly specialized talent.

Competitive Landscape

SB Pharma Solutions competes in the medical affairs consulting space against a range of players, from individual consultants and boutique agencies to large, global contract research organizations (CROs) that offer medical writing and affairs as part of broader service portfolios. Its differentiation lies in its focused niche (small-to-mid-size pharma), senior-level involvement, and flexible, partnership-oriented model.